(Q45022878)

8 December 2017

title

Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping (English)

1 reference

8 December 2017

1 reference

4

1 reference

8 December 2017

Myong-Jin Kim

1

1 reference

8 December 2017

Anne N Nafziger

2

1 reference

8 December 2017

Yanhua Zhang

3

1 reference

8 December 2017

Andrea Gaedigk

5

1 reference

8 December 2017

Joseph S Bertino

6

1 reference

8 December 2017

publication date

1 September 2004

1 reference

The Journal of Clinical Pharmacology

8 December 2017

published in

1 reference

8 December 2017

volume

44

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

966-973

1 reference

Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

21 January 2018

Gerontokinetics--a reply

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Genetic polymorphism of S-mephenytoin hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268910

21 January 2018

Identifiers

DOI

10.1177/0091270004268910

1 reference

8 December 2017

1 reference